From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn’s disease
出版年份 2015 全文链接
标题
From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn’s disease
作者
关键词
-
出版物
Therapeutic Advances in Gastroenterology
Volume 8, Issue 3, Pages 143-159
出版商
SAGE Publications
发表日期
2015-03-17
DOI
10.1177/1756283x15576462
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study
- (2014) W. J. Sandborn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Inflammatory bowel disease: Pathogenesis
- (2014) Yi-Zhen Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy and Safety of Certolizumab Pegol for Crohn’s Disease: A Systematic Review and Meta-Analysis
- (2013) Wei Da et al. ADVANCES IN THERAPY
- Current and emerging strategies in the management of Crohn's disease
- (2013) Charles Randall et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Biologic therapy for autoimmune diseases: an update
- (2013) Ziv Rosman et al. BMC Medicine
- Crohn’s disease: A review of treatment options and current research
- (2013) Sean Bandzar et al. CELLULAR IMMUNOLOGY
- Association Between Plasma Concentrations of Certolizumab Pegol and Endoscopic Outcomes of Patients With Crohn's Disease
- (2013) Jean–Frédéric Colombel et al. Clinical Gastroenterology and Hepatology
- Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn's and Colitis Epidemiology Study
- (2013) Siew C. Ng et al. GASTROENTEROLOGY
- Efficacy and Safety of Natalizumab in Crohn’s Disease Patients Treated at 6 Boston Academic Hospitals
- (2013) Pascal Juillerat et al. INFLAMMATORY BOWEL DISEASES
- Natalizumab in Crohn’s Disease
- (2013) Atsushi Sakuraba et al. INFLAMMATORY BOWEL DISEASES
- Mucosal Healing Is Associated with Improved Long-term Outcome of Maintenance Therapy with Natalizumab in Crohnʼs Disease
- (2013) Atsushi Sakuraba et al. INFLAMMATORY BOWEL DISEASES
- The burden of inflammatory bowel disease in Europe
- (2013) Johan Burisch et al. Journal of Crohns & Colitis
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease
- (2013) Satish Keshav et al. PLoS One
- Changing Incidence of Inflammatory Bowel Disease: Environmental Influences and Lessons Learnt from the South Asian Population
- (2013) Alice Foster et al. Frontiers in Pediatrics
- A Pooled Analysis of Infections, Malignancy and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease
- (2012) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
- (2012) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
- (2012) Uma Mahadevan et al. Clinical Gastroenterology and Hepatology
- Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure
- (2012) Zuzana Zelinkova et al. Clinical Gastroenterology and Hepatology
- Biologics-induced autoimmune diseases
- (2012) Roberto Perez-Alvarez et al. CURRENT OPINION IN RHEUMATOLOGY
- Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
- (2012) Paul Rutgeerts et al. GASTROENTEROLOGY
- Natalizumab for moderate to severe Crohnʼs disease in clinical practice: The Mayo Clinic Rochester experience
- (2012) S. V. Kane et al. INFLAMMATORY BOWEL DISEASES
- Crohn's disease
- (2012) Daniel C Baumgart et al. LANCET
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictors of dose escalation of adalimumab in a prospective cohort of Crohn’s disease patients
- (2011) E. Bultman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
- (2011) Vincent Billioud et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Certolizumab Pegol Compared to Natalizumab in Patients with Moderate to Severe Crohn’s Disease: Results of a Decision Analysis
- (2011) Ashwin N. Ananthakrishnan et al. DIGESTIVE DISEASES AND SCIENCES
- Blocking Lymphocyte Localization to the Gastrointestinal Mucosa as a Therapeutic Strategy for Inflammatory Bowel Diseases
- (2011) Eduardo J. Villablanca et al. GASTROENTEROLOGY
- Epidemiology and Natural History of Inflammatory Bowel Diseases
- (2011) Jacques Cosnes et al. GASTROENTEROLOGY
- Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial
- (2011) Gert Van Assche et al. GUT
- Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease
- (2011) Shomron Ben-Horin et al. Journal of Crohns & Colitis
- Maintenance of clinical benefit in Crohn’s disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort
- (2010) A. W. G. Waugh et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics
- (2010) Uma Mahadevan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine
- (2010) T. T. MACDONALD et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Reinduction With Certolizumab Pegol in Patients With Relapsed Crohn's Disease: Results From the PRECiSE 4 Study
- (2010) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab
- (2010) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months
- (2010) Gary R. Lichtenstein et al. Clinical Gastroenterology and Hepatology
- Importance of disrupted intestinal barrier in inflammatory bowel diseases
- (2010) Saʼad Y. Salim et al. INFLAMMATORY BOWEL DISEASES
- Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease
- (2010) Kuldeep Cheent et al. Journal of Crohns & Colitis
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions
- (2009) A. Vultaggio et al. ALLERGY
- Management of Crohn's Disease in Adults
- (2009) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- 392 PROTECT-1 Study Demonstrated Efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Treatment of Patients with Moderate to Severe Crohn's Disease
- (2009) Satish Keshav et al. GASTROENTEROLOGY
- Low counts of Faecalibacterium prausnitzii in colitis microbiota
- (2009) H. Sokol et al. INFLAMMATORY BOWEL DISEASES
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
- (2009) Gert Van Assche et al. Journal of Crohns & Colitis
- Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
- (2008) Brian G. Feagan et al. Clinical Gastroenterology and Hepatology
- Extraintestinal manifestations of inflammatory bowel disease
- (2008) S. Ardizzone et al. DIGESTIVE AND LIVER DISEASE
- A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
- (2008) William J. Sandborn et al. GASTROENTEROLOGY
- JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
- (2008) J Verbeeck et al. GUT
- Mucosal cytokine network in inflammatory bowel disease
- (2008) Akira Andoh et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Review: Efficacy and safety of adalimumab in Crohn's disease
- (2008) Gary R. Lichtenstein et al. Therapeutic Advances in Gastroenterology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started